Advertisement

Topics

Osteoporosis Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $2000

09:03 EST 12 Nov 2017 | BioPortfolio Reports

Osteoporosis Pipeline Review, H2 2017


Summary


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis Pipeline Review, H2 2017, provides an overview of the Osteoporosis Metabolic Disorders pipeline landscape.


Osteoporosis, or thinning bones, makes bones weak and more likely to break. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or menopause, smoking, and some medications. Signs and symptoms include back pain, caused by a fractured or collapsed vertebra, loss of height over time, a stooped posture, a bone fracture that occurs much more easily than expected. Prevention and treatment include calcium and vitamin D, exercise, and osteoporosis medications.


Report Highlights


Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Osteoporosis Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Osteoporosis Metabolic Disorders, complete with analysis by stage of development, drug target, mechanism of action MoA, route of administration RoA and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.


The Osteoporosis Metabolic Disorders pipeline guide also reviews of key players involved in therapeutic development for Osteoporosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in PreRegistration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 7, 5, 5, 13, 1, 55 and 13 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 11 and 14 molecules, respectively.


Osteoporosis Metabolic Disorders pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The pipeline guide provides a snapshot of the global therapeutic landscape of Osteoporosis Metabolic Disorders.

The pipeline guide reviews pipeline therapeutics for Osteoporosis Metabolic Disorders by companies and universities/research institutes based on information derived from company and industryspecific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from preregistration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, RD brief, MoA other developmental activities.

The pipeline guide reviews key companies involved in Osteoporosis Metabolic Disorders therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Osteoporosis Metabolic Disorders therapeutics based on mechanism of action MoA, drug target, route of administration RoA and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Osteoporosis Metabolic Disorders


Reasons to buy


Procure strategically important competitor information, analysis, and insights to formulate effective RD strategies.

Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.

Find and recognize significant and varied types of therapeutics under development for Osteoporosis Metabolic Disorders.

Classify potential new clients or partners in the target demographic.

Develop tactical initiatives by understanding the focus areas of leading companies.

Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

Formulate corrective measures for pipeline projects by understanding Osteoporosis Metabolic Disorders pipeline depth and focus of Indication therapeutics.

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the knowhow what drove them from pipeline.

Original Article: Osteoporosis Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $2000

NEXT ARTICLE

More From BioPortfolio on "Osteoporosis Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $2000"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...